Advertisement

Combined Enzymatic Degradation with Chondroitinases and Alcian Blue Precipitation in Determination of Urinary Chondroitin Sulphates

  • B. Fellström
  • B. G. Danielson
  • S. Ljunghall
  • B. Wikström

Abstract

It has been claimed that glycosaminoglycans are important inhibitors of calcium oxalate crystal growth and aggregation1. The mode of action as inhibitors may be through a binding of the glycosaminoglycans to the crystal surface and thereby blocking the growth sites of the crystals2. Chondroitin sulphates can also be recovered from calcium oxalate crystals after dissolution of crystals grown in urine3. The alcian blue precipitation method4is not specific for urinary glycosaminoglycans, but also precipitates polyanionic urinary glycoproteins and possibly ribonucleic acid residues. Using this method it has been shown that stone formers have a lower urinary excretion of polyanions, that are precipitable by alcian blue5. The purpose of the present study was to measure glycosaminoglycans specifically in unconcentrated urine.

Keywords

Urinary Excretion Heparan Sulphate Chondroitin Sulphate Alcian Blue High Excretion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    W. G. Robertson, M. Peacock, and B. E. C. Nordin, Clin. Chim. Acta 43:31 (1973).PubMedCrossRefGoogle Scholar
  2. 2.
    B. Fellström, B. G. Danielson, F. A. Karlsson, and S. Ljunghall, in: “Urolithiasis and Related Clinical Research”, P. O. Schwille, L. H. Smith, W. G. Robertson, and W. Vahlensieck, eds., Plenum, New York (1985).Google Scholar
  3. 3.
    J. G. Brockis, R. C. Bowyer, and R. K. McCulloch, Scand. J. Urol. Nephrol. Suppl. 53:67 (1979).Google Scholar
  4. 4.
    P. Whiteman, Biochem. J. 131:343 (1973).PubMedGoogle Scholar
  5. 5.
    W. G. Robertson, M. Peacock, P. J. Heyburn, D. H. Marshall, and P. B. Clark, Br. J. Urol. 50:449 (1978).PubMedCrossRefGoogle Scholar
  6. 6.
    B. Glimelius, B. Norling, B. Westermark, and A. Wasteson, Biochem. J. 172:443 (1978).PubMedGoogle Scholar
  7. 7.
    D. P. Varadi, J. A. Cifonelli, and A. Dorfman, Biochim. Biophys. Acta 141:103 (1967).PubMedCrossRefGoogle Scholar
  8. 8.
    E. Wessler, Biochem. J. 122:373 (1971).PubMedGoogle Scholar
  9. 9.
    R. Caudarella, F. Stefani, E. Rizzoli, N. Malavolta, and G. D. Antuono, J. Urol. 129:665 (1983).PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • B. Fellström
    • 1
  • B. G. Danielson
    • 1
  • S. Ljunghall
    • 1
  • B. Wikström
    • 1
  1. 1.Dept. of Internal MedicineUniversity HospitalUppsalaSweden

Personalised recommendations